1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families
2025) In European Journal of Human Genetics(
- Contribution to journal › Article
- 2024
-
Mark
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
(
- Contribution to journal › Article
-
Mark
Germline copy number variants and endometrial cancer risk
(
- Contribution to journal › Article
- 2023
-
Mark
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer : Data from the Swedish TP53 Study
(
- Contribution to journal › Article
-
Mark
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
(
- Contribution to journal › Article
- 2021
-
Mark
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
(
- Contribution to journal › Article
- 2020
-
Mark
Public support for healthcare-mediated disclosure of hereditary cancer risk information : Results from a population-based survey in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Functional characterization of novel germline TP53 variants in Swedish families
(
- Contribution to journal › Article
- 2018
-
Mark
Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2
(
- Contribution to journal › Article